WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemother...
By Mil Arcega Washington, DC 19 September 2006 watch report on E Coli The United States Food and Drug Administration (F.D.A.) has expanded its search for the source of the deadly E.Coli bacterium that has already killed one woman and sickened more t...
